Rimactan Hart hylki 300 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

rimactan hart hylki 300 mg

sandoz gmbh* - rifampicinum inn - hart hylki - 300 mg

Rimactan Hart hylki 150 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

rimactan hart hylki 150 mg

sandoz gmbh* - rifampicinum inn - hart hylki - 150 mg

Atozet Filmuhúðuð tafla 10 mg/20 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

atozet filmuhúðuð tafla 10 mg/20 mg

n.v. organon* - ezetimibum inn; atorvastatinum kalsíum - filmuhúðuð tafla - 10 mg/20 mg

Atozet Filmuhúðuð tafla 10 mg/40 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

atozet filmuhúðuð tafla 10 mg/40 mg

n.v. organon* - ezetimibum inn; atorvastatinum kalsíum - filmuhúðuð tafla - 10 mg/40 mg

Atozet Filmuhúðuð tafla 10 mg/80 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

atozet filmuhúðuð tafla 10 mg/80 mg

n.v. organon* - ezetimibum inn; atorvastatinum kalsíum - filmuhúðuð tafla - 10 mg/80 mg

Lipistad Filmuhúðuð tafla 20 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

lipistad filmuhúðuð tafla 20 mg

stada arzneimittel ag - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 20 mg

Lipistad Filmuhúðuð tafla 40 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

lipistad filmuhúðuð tafla 40 mg

stada arzneimittel ag - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 40 mg

Lipistad Filmuhúðuð tafla 80 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

lipistad filmuhúðuð tafla 80 mg

stada arzneimittel ag - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 80 mg

Zepatier Den europeiske union - islandsk - EMA (European Medicines Agency)

zepatier

merck sharp & dohme b.v. - elbasvir, grazoprevir - lifrarbólga c, langvinn - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 og 5. fyrir lifrarbólgu c veira (hcv) arfgerð-sérstakur starfsemi sjá kafla 4. 4 og 5.

Descovy Den europeiske union - islandsk - EMA (European Medicines Agency)

descovy

gilead sciences ireland uc - meðferð með eviplera nýrnastarfsemi alafenamide - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).